These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9504439)

  • 1. ATP-sensitive potassium-channel-opening activity of CL-065, a 3-[(substituted-carbonyl)amino]-2H-1-benzopyran, in the rat.
    Chen MJ; Lee YM; Sheu JR; Hu CT; Yen MH
    J Pharm Pharmacol; 1998 Jan; 50(1):83-90. PubMed ID: 9504439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a newly synthesized ATP-sensitive potassium channel opener, MJ-355, on blood pressure and myocardial ischemia-reperfusion injury in rats.
    Lee YM; Peng YY; Sheu JR; Cheng CY; Yen MH
    Jpn J Pharmacol; 1999 Oct; 81(2):185-93. PubMed ID: 10591476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I; Pratz J; Mondot S
    Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Kwan YW; To KW; Lau WM; Tsang SH
    Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiating effect of nicorandil on the adenosine A2 receptor-mediated vasodepression in rats: potential role for KATP channels.
    Saito K; Sakai K
    Fundam Clin Pharmacol; 1998; 12(2):143-51. PubMed ID: 9565767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
    Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
    Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of novel 2-(alpha-alkoxyimino)benzylpyridine derivatives as K+ channel openers.
    Maekawa T; Yamamoto S; Igata Y; Ikeda S; Watanabe T; Shiraishi M
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1994-2004. PubMed ID: 9433769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta.
    Yamashita T; Masuda Y; Tanaka S
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):914-20. PubMed ID: 7898074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim.
    Saito K; Sakai K
    Fundam Clin Pharmacol; 1998; 12(1):37-43. PubMed ID: 9523182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation.
    Ng CF; Koon CM; Cheung DW; Lam MY; Leung PC; Lau CB; Fung KP
    J Ethnopharmacol; 2011 Oct; 137(3):1366-72. PubMed ID: 21855622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T; Iwai T; Haruta K; Takeda K
    Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.